Description
Recombinant monoclonal antibody to CD95. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma LOB3-11.
Target
CD95
Target Alias Names
Tumor necrosis factor receptor superfamily member 6, FAS, Apo-1 antigen, Apoptosis-mediating surface antigen FAS, FASLG receptor
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression